Novartis opens new pharmaceutical plant and intends to build biotech facility in Singapore

Novartis also expects to invest USD 700 million to build large-scale biotechnology facility in Singapore to support the company's growing pipeline of biopharmaceuticals

31-Oct-2007 - The Singapore Economic Development Board anoounced that Novartis officially inaugurated a new state-of-the-art pharmaceutical manufacturing site in Tuas, Singapore, adding capacity to its global production network to meet business growth and support new product launches in the US and Japanese ...

Genentech to set up Singapore's first Microbial-Based Biopharmaceutical Manufacturing Facility

Fourth Biologics Facility in Less Than 2 Years Helps Establish Singapore as a Serious Player in Biologics Manufacturing

29-Mar-2007 - Singapore's efforts to grow its biologics manufacturing sector received a significant boost when the Singapore Economic Development Board (EDB) announced that Genentech, Inc. has decided to establish a commercial scale microbial-based biologics manufacturing facility in Singapore - a first for ...

Lilly Expands Drug Discovery Efforts in Singapore

Broader Research Focus Will Leverage Local and Regional Talent

28-Mar-2007 - Eli Lilly and Company announced a USD $150 million expansion, over the next five years, of its state-of-the-art drug discovery research activities at the Lilly Centre for Systems Biology (LSB). The project, a partnership with the Singapore Economic Development Board (EDB), will take advantage of ...

Biopolis Expansion Confirms Singapore's Growing Role As A Global Biomedical Sciences Hub

22-Jun-2005 - The demand for research laboratories at Singapore's Biopolis, a purpose-built biomedical R&D hub, has been so strong that development of phase II is already underway less than 2 years after Biopolis opened. Phase I with 2 million square feet of space is over 90 per cent occupied. Phase II with ...

Singapore Sustains R&D in Science and Technology - increase in demand for PhD researchers is evident in 'biomedical sciences'

2003 R&D Survey reveals private sector's continued investments in R&D

14-Dec-2004 - Private sector R&D investment in Singapore continues to grow as more companies are engaging in R&D activities and employing PhD trained researchers. This is revealed in the results of the 2003 R&D Survey released by the Agency for Science, Technology and Research (A*STAR). The number of PhD ...

British High Commission in Singapore Opens Science and Tech Office at research hub Biopolis

Singapore Life-Sciences Company Opens Research and Production Facility

01-Dec-2004 - The British High Commission opened a new Science and Technology Office at the Biopolis. While the high commission has more than 20 science and technology offices around the world, its unit at Biopolis' Helios building is the first to be located in a research hub. The British High Commission is ...

Singapore Cuts Cost and Time-to-Revenue for Biomedical Sciences Companies

Singapore is an Ideal Location for Biomedical Sciences Manufacturing and R&D

10-Jun-2004 - San Francisco. A growing number of biomedical companies are setting up research operations in Singapore to take advantage of its world-class R&D environment, where state-of-the art facilities, and the availability of shared facilities and services can cut R&D costs significantly and accelerate ...